Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel Rodriguez

Showing results (211-220 of 313) with videos related to

Pageof 32
Sort By:
Cell Reports|June 15, 2026
Convergent molecular signatures across eating disorders and obsessive-compulsive disorder in the human brainMichael S Breen, Ran Tao, Andy Yang, et al.
Medrxiv : the Preprint Server for Health Sciences|December 9, 2024
Convergent molecular signatures across eating disorders and obsessive-compulsive disorder in the human brainMichael S Breen, Ran Tao, Andy Yang, et al.
Journal of Hepatology|October 10, 2020
Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosisCatherine Frenette, Zeid Kayali, Edward Mena, et al.
The Journal of Nutrition|September 17, 2020
Fried-Food Consumption Does Not Increase the Risk of Stroke in the Spanish Cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC) StudyJimena Rey-García, Pilar Guallar-Castillón, Carolina Donat-Vargas, et al.
Oncotarget|January 22, 2015
Hypoxia induces a lipogenic cancer cell phenotype via HIF1α-dependent and -independent pathwaysAlessandro Valli, Miguel Rodriguez, Loukas Moutsianas, et al.
Frontiers in Oncology|June 27, 2022
Validation of a Monte Carlo Framework for Out-of-Field Dose Calculations in Proton TherapyMarijke De Saint-Hubert, Nico Verbeek, Christian Bäumer, et al.
Nature Communications|March 31, 2026
Trisomy 21 Drives ADARB1 Overexpression and Premature RNA Recoding in the Developing Fetal BrainMichael S Breen, Andy Yang, Xuran Wang, et al.
Cancer|October 4, 2013
Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapyAtin Agarwal, George J Chang, Chung-Yuan Hu, et al.
Biorxiv : the Preprint Server for Biology|November 23, 2022
Inflammation durably imprints memory CD4+ T cellsSophie L Gray-Gaillard, Sabrina Solis, Han M Chen, et al.
Clinical Colorectal Cancer|February 7, 2022
Intraoperative Radiation After Pelvic Short Course Radiation-Based Total Neoadjuvant Therapy for Patients With Rectal Adenocarcinoma at High Risk for Local RecurrenceZooha Khan, Michael K Rooney, Prajnan Das, et al.
Pageof 32

Showing results (211-220 of 313) with videos related to

Sort By:
Pageof 32
Cell Reports|June 15, 2026
Convergent molecular signatures across eating disorders and obsessive-compulsive disorder in the human brainMichael S Breen, Ran Tao, Andy Yang, et al.
Medrxiv : the Preprint Server for Health Sciences|December 9, 2024
Convergent molecular signatures across eating disorders and obsessive-compulsive disorder in the human brainMichael S Breen, Ran Tao, Andy Yang, et al.
Journal of Hepatology|October 10, 2020
Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosisCatherine Frenette, Zeid Kayali, Edward Mena, et al.
The Journal of Nutrition|September 17, 2020
Fried-Food Consumption Does Not Increase the Risk of Stroke in the Spanish Cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC) StudyJimena Rey-García, Pilar Guallar-Castillón, Carolina Donat-Vargas, et al.
Oncotarget|January 22, 2015
Hypoxia induces a lipogenic cancer cell phenotype via HIF1α-dependent and -independent pathwaysAlessandro Valli, Miguel Rodriguez, Loukas Moutsianas, et al.
Frontiers in Oncology|June 27, 2022
Validation of a Monte Carlo Framework for Out-of-Field Dose Calculations in Proton TherapyMarijke De Saint-Hubert, Nico Verbeek, Christian Bäumer, et al.
Nature Communications|March 31, 2026
Trisomy 21 Drives ADARB1 Overexpression and Premature RNA Recoding in the Developing Fetal BrainMichael S Breen, Andy Yang, Xuran Wang, et al.
Cancer|October 4, 2013
Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapyAtin Agarwal, George J Chang, Chung-Yuan Hu, et al.
Biorxiv : the Preprint Server for Biology|November 23, 2022
Inflammation durably imprints memory CD4+ T cellsSophie L Gray-Gaillard, Sabrina Solis, Han M Chen, et al.
Clinical Colorectal Cancer|February 7, 2022
Intraoperative Radiation After Pelvic Short Course Radiation-Based Total Neoadjuvant Therapy for Patients With Rectal Adenocarcinoma at High Risk for Local RecurrenceZooha Khan, Michael K Rooney, Prajnan Das, et al.
Pageof 32